Logo
x

Search

Subscribe Now

Oral Suspension

Astellas Reports the US FDA's Acceptance of Priority Review for its NDO Therapy

Astellas Reports the US FDA's Acceptance of Priority Review for its NDO Therapy

  • January 7, 2021
Novartis Voluntary Nationwide Recalls Three Lots of Promacta (eltrombopag- 12.5 mg) Oral Suspension Due to Peanut Contamination

Novartis Voluntary Nationwide Recalls Three Lots of Promacta (eltrombopag- 12.5 mg) Oral Suspension Due to Peanut Contamination

  • May 13, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.